• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Mammography business causes ANMR loss

Article

Advanced NMR reported a $1.7 million net loss for its 1995 fiscalyear (end-September), primarily due to losses incurred by itsAdvanced Mammography Systems subsidiary. AMS is awaiting regulatoryclearance to begin marketing a dedicated MR mammography

Advanced NMR reported a $1.7 million net loss for its 1995 fiscalyear (end-September), primarily due to losses incurred by itsAdvanced Mammography Systems subsidiary. AMS is awaiting regulatoryclearance to begin marketing a dedicated MR mammography scanner(SCAN 3/15/95).

Advanced NMR, of Wilmington, MA, said the loss came on revenuesof $8.6 million. ANMR's 1995 fiscal year only included revenuesfor nine months because it changed its fiscal year-end to Sept.30 from Dec. 31 when it merged with imaging services firm MedicalDiagnostics (MDI).

ANMR said the company would have been marginally profitablein fiscal 1995 were it not for losses incurred by Advanced MammographySystems. In addition, ANMR's results included only one month ofrevenue from MDI. ANMR believes MDI will contribute $25 millionin revenue in fiscal 1996.

For the comparable nine months of 1994, ANMR posted revenuesof $5.2 million and a net loss of $1.3 million.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.